Mar 19,2014

New Propeller Provider Dashboard Saves Time and Clicks

Propeller Health is excited to announce a new dashboard for health care providers is now live! The changes are direct result of the providers' feedback.

PRODUCT

#software

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 16,2014

Space Institute Funds Eye Tracking Technology And Software-Enabled Therapeutics For Brain Health

The EyeBox (cns), a diagnostic device developed to assess brain health through tracking eye movement, and eFormulations, software enabled therapeutics which combine prescription medicines with customized software apps for brain-related conditions, have both been funded for further development by the National Space Biomedical Research Institute (NSBRI). EyeBox (cns) is developed by Oculogica, Inc. of New York City, and eFormulations, by a therapeutic platform by Pear Therapeutics, Inc. of Boston. eFormulations provide the only way to simultaneously impact brain experience as well as brain chemistry. That combination provides an extremely powerful way to treat brain-related disorders.

PRODUCT

#software

View Analyst & Ambassador Comments
Go to original news
May 01,2014

LabStyle Innovations Receives U.S. Notice of Allowance for Key Patent Relating to the Dario™ Blood Glucose Monitoring Device

LabStyle Innovations Corp., developer of the Dario™ Diabetes Management Solution, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the company's personalized blood glucose monitoring device.

PRODUCT

#connected device

#software

View Analyst & Ambassador Comments
Go to original news
Jun 17,2014

LabStyle Innovations Reports Positive Results From the Initial Commercial Launch of Dario™ Smart Meter

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today provided a positive update on the initial "soft" launch of the Dario™ Smart Meter in the company's initial target jurisdictions of the United Kingdom, Italy and New Zealand.

PRODUCT

#connected device

#software

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 20,2022

DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform

Global digital therapeutics (DTx) company DarioHealth Corp. (Nasdaq: DRIO) announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment. The technology enables automated MSK and injury risk screenings with validated accuracy and Physimax’s Artificial Intelligence (AI) engine generates evidence-based personal training programs.

COLLABORATION MERGERS & ACQUISITION

#product & service

#software

View Analyst & Ambassador Comments
Go to original news
Feb 08,2022

EHE Health and Welldoc Announce Strategic Partnership to Launch Thrive Now, First Comprehensive Preventive Health Companion

Today, EHE Health, a national healthcare provider network, and Welldoc announced a partnership to launch Thrive Now by EHE Health, a digital health platform designed to help manage members’ overall total health. Thrive Now leverages Welldoc’s evidence-based platform solution to integrate multiple dimensions of health with the insights and data visualizations necessary to empower individuals and strengthen care team connections. Thrive Now will officially launch in April and is the third product innovation under EHE Health’s Pulse™ offering.

COLLABORATION PARTNERSHIP

#product & service

#coaching

#software

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions

The study found that nearly two thirds of Dario participants with a BMI of more than 30 reduced their BMI by an average of 2.8 units with an average weight loss of 7.4% (p≤0.05). In addition, the study also examined a subgroup of Dario participants with BMIs greater than 30 and high-risk blood glucose readings of more than 180 mg/dL to understand the impact on both diabetes and weight management. This subgroup also demonstrated improved clinical outcomes, reducing their weight by an average of 4.9% and reducing their average blood glucose by 16.1% over a 12-months period.

CLINICAL STUDY

#mobile app

#coaching

#software

View Analyst & Ambassador Comments
Go to original news
Jun 24,2022

Hygieia Advances its Global Business Development Activities with d-Nav® Program in Israel

Hygieia, a digital therapeutics company for insulin therapy, has successfully licensed its d-Nav insulin management technology to Movement Group, a provider of health and wellness programs to integrated health delivery networks in Israel. The agreement is part of an accelerated strategy to expand its d-Nav insulin titration technology globally.

COLLABORATION PARTNERSHIP

#product & service

#software

View Analyst & Ambassador Comments
Go to original news
Jul 26,2022

Hygieia announces new CPT codes for autonomous insulin dose titration

Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology. d-Nav is the first FDA-cleared technology to autonomously adjust insulin dose recommendations to correspond to a patient’s changing insulin needs. Patients get the correct insulin dose at each injection, without the need for physician intervention.

PRODUCT

#reimbursement

#software

View Analyst & Ambassador Comments
Go to original news
Aug 30,2022

Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program

Hygieia, a provider of digital therapeutics for insulin management, has added Metro Detroit Endocrinology Center in Dearborn as a clinical partner. The partnership extends Hygieia’s d-Nav® network and makes autonomous insulin therapy service available for an underserved population.

COLLABORATION PARTNERSHIP

#institution

#software

View Analyst & Ambassador Comments
Go to original news
Subscribe to SOFTWARE